Air pollution: mechanisms of neuroinflammation and CNS disease

Trends in Neurosciences

Volumn 32, Issue 9, 2009, Pages 506-516

  Block, Michelle L ^a   Calderón Garcidueñas, Lilian ^b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BLACK CARBON; CARBON MONOXIDE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; NICKEL; NITROGEN DIOXIDE; OZONE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VANADIUM;

ABSORPTION; AIR POLLUTION; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; EXHAUST GAS; HUMAN; INNATE IMMUNITY; MACROGLIA; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW;

AIR POLLUTANTS; AIR POLLUTION; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; INFLAMMATION; NEUROGLIA; REACTIVE OXYGEN SPECIES;

EID: 69949111672     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2009.05.009     Document Type: Review

References (105)

1. Block M.L., et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8 (2007) 57-69
2. Craig L., et al. Air pollution and public health: a guidance document for risk managers. J. Toxicol. Environ. Health A 71 (2008) 588-698
3. Riedl M.A. The effect of air pollution on asthma and allergy. Curr. Allergy Asthma Rep. 8 (2008) 139-146
4. Mills N.L., et al. Adverse cardiovascular effects of air pollution. Nat. Clin. Pract. Cardiovasc. Med. 6 (2009) 36-44
5. Akimoto H. Global air quality and pollution. Science 302 (2003) 1716-1719
6. Muhlfeld C., et al. Interactions of nanoparticles with pulmonary structures and cellular responses. Am. J. Physiol. Lung Cell. Mol. Physiol. 294 (2008) L817-829
7. Valavanidis A., et al. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 26 (2008) 339-362
8. Rothen-Rutishauser B., et al. A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. ALTEX 25 (2008) 191-196
9. Simkhovich B.Z., et al. Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J. Am. Coll. Cardiol. 52 (2008) 719-726
10. Thomson E.M., et al. Air pollution alters brain and pituitary endothelin-1 and inducible nitric oxide synthase gene expression. Environ. Res. 105 (2007) 224-233
11. Calderon-Garciduenas L., et al. Air pollution and brain damage. Toxicol. Pathol. 30 (2002) 373-389
12. Calderon-Garciduenas L., et al. DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol. Pathol. 31 (2003) 524-538
13. Peters A., et al. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part. Fibre Toxicol. 3 (2006) 13
14. Calderon-Garciduenas L., et al. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol. Pathol. 32 (2004) 650-658
15. Oberdorster G., et al. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16 (2004) 437-445
16. Zhang Z.F., et al. Indoor air pollution of coal fumes as a risk factor of stroke. Shanghai. Am. J. Public. Health. 78 (1988) 975-977
17. Lloyd-Jones D., et al. Heart disease and stroke statistics - 2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2008) 480-486
18. Lokken P.R., et al. Air pollution and risk of stroke: underestimation of effect due to misclassification of time of event onset. Epidemiology 20 (2009) 137-142
19. Lisabeth L.D., et al. Ambient air pollution and risk for ischemic stroke and transient ischemic attack. Ann. Neurol. 64 (2008) 53-59
20. Hong Y.C., et al. Air pollution: a new risk factor in ischemic stroke mortality. Stroke 33 (2002) 2165-2169
21. Kettunen J., et al. Associations of fine and ultrafine particulate air pollution with stroke mortality in an area of low air pollution levels. Stroke 38 (2007) 918-922
22. Seagrave J., et al. Lung toxicity of ambient particulate matter from southeastern U. S. sites with different contributing sources: relationships between composition and effects. Environ. Health Perspect. 114 (2006) 1387-1393
23. Hirtz D., et al. How common are the "common" neurologic disorders?. Neurology 68 (2007) 326-337
24. Wimo A., et al. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn. Disord. 21 (2006) 175-181
25. Thomas B., and Beal M.F. Parkinson's disease. Hum. Mol. Genet. 16 S2 (2007) R183-R194
26. Doty R.L. The olfactory vector hypothesis of neurodegenerative disease: is it viable?. Ann. Neurol. 63 (2008) 7-15
27. Calderon-Garciduenas L., et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol. Pathol. 36 (2008) 289-310
28. Calderon-Garciduenas L., et al. Air pollution, cognitive deficits and brain abnormalities: a pilot study with children and dogs. Brain Cogn. 68 (2008) 117-127
29. Campbell A., et al. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 26 (2005) 133-140
30. Kleinman M.T., et al. Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways. Toxicol. Lett. 178 (2008) 127-130
31. Sirivelu M.P., et al. Activation of the stress axis and neurochemical alterations in specific brain areas by concentrated ambient particle exposure with concomitant allergic airway disease. Environ. Health Perspect. 114 (2006) 870-874
32. Zanchi A.C., et al. Chronic nasal instillation of residual-oil fly ash (ROFA) induces brain lipid peroxidation and behavioral changes in rats. Inhal. Toxicol. 20 (2008) 795-800
33. Colvin V.L., and Kulinowski K.M. Nanoparticles as catalysts for protein fibrillation. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8679-8680
34. Cedervall T., et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2050-2055
35. Lynch I., et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 134-135 (2007) 167-174
36. Liu L., et al. Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. J. Mol. Biol. 377 (2008) 1236-1250
37. Qin Z., et al. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J. Biol. Chem. 282 (2007) 5862-5870
38. Carvey P.M., et al. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplant. 15 (2006) 239-250
39. Mikaeloff Y., et al. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 130 (2007) 2589-2595
40. Finkelstein M., and Jerrett M. A study of the relationships between Parkinson's disease and markers of traffic-derived environmental maganese air pollution in two Canadian cities. Environ. Res. 104 (2007) 420-432
41. Veronesi B., et al. Effects of subchronic exposures to concentrated ambient particles. VII. Degeneration of dopaminergic neurons in Apo E-/- mice. Inhal. Toxicol 17 (2005) 235-241
42. McColl B.W., et al. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158 (2009) 1049-1061
43. Castillo J., et al. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J. Neurol. 256 (2009) 217-224
44. Cunningham C., et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 65 (2009) 304-312
45. D'Mello C., et al. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 29 (2009) 2089-2102
46. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56
47. Tracey K.J. Reflex control of immunity. Nat. Rev. Immunol. 9 (2009) 418-428
48. Tamagawa E., and van Eeden S.F. Impaired lung function and risk for stroke: role of the systemic inflammation response?. Chest 130 (2006) 1631-1633
49. Folkmann J.K., et al. Oxidatively damaged DNA and inflammation in the liver of dyslipidemic ApoE-/- mice exposed to diesel exhaust particles. Toxicology 237 (2007) 134-144
50. Swiston J.R., et al. Wood smoke exposure induces a pulmonary and systemic inflammatory response in firefighters. Eur. Respir. J. 32 (2008) 129-138
51. Ruckerl R., et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ. Health Perspect. 115 (2007) 1072-1080
52. Calderon-Garciduenas L., et al. Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants. Inhal. Toxicol. 20 (2008) 499-506
53. Qin L., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 (2007) 453-462
54. Rivest S., et al. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc. Soc. Exp. Biol. Med. 223 (2000) 22-38
55. Perry V.H., et al. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immuno.l 7 (2007) 161-167
56. Ling Z., et al. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp. Neurol. 199 (2006) 499-512
57. Manousakis G., et al. The interface between stroke and infectious disease: infectious diseases leading to stroke and infections complicating stroke. Curr. Neurol. Neurosci. Rep. 9 (2009) 28-34
58. Nemmar A., and Inuwa I.M. Diesel exhaust particles in blood trigger systemic and pulmonary morphological alterations. Toxicol. Lett. 176 (2008) 20-30
59. Wang J., et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology 254 (2008) 82-90
60. Wang B., et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol. Trace Elem. Res. 118 (2007) 233-243
61. Geiser M., et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 113 (2005) 1555-1560
62. Niwa Y., et al. Inhalation exposure to carbon black induces inflammatory response in rats. Circ. J. 72 (2008) 144-149
63. Tin Tin Win, S. et al. (2008) Changes in neurotransmitter levels and proinflammatory cytokine mRNA expressions in the mice olfactory bulb following nanoparticle exposure. Toxicol. Appl. Pharmacol. 226, 192-198
64. Veronesi B., et al. The surface charge of visible particulate matter predicts biological activation in human bronchial epithelial cells. Toxicol. Appl. Pharmacol. 178 (2002) 144-154
65. Veronesi B., et al. Electrostatic charge activates inflammatory vanilloid (VR1) receptors. Neurotoxicology 24 (2003) 463-473
66. Long T.C., et al. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ. Health Perspect. 115 (2007) 1631-1637
67. Silva G.A. Neuroscience nanotechnology: progress, opportunities and challenges. Nat. Rev. Neurosci. 7 (2006) 65-74
68. Ma J.Y., and Ma J.K. The dual effect of the particulate and organic components of diesel exhaust particles on the alteration of pulmonary immune/inflammatory responses and metabolic enzymes. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 20 (2002) 117-147
69. Burton N.C., and Guilarte T.R. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ. Health Perspect. 117 (2009) 325-332
70. Lucchini, R. et al. (2003) Exposure to neurotoxic metals and prevalence of parkinsonian syndrome in the area of Brescia. G. Ital. Med. Lav. Ergon. 25 Suppl, 88-89
71. Pryor W.A., et al. A new mechanism for the toxicity of ozone. Toxicol. Lett. 82-83 (1995) 287-293
72. Pryor W.A. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radic. Biol. Med. 17 (1994) 451-465
73. Hollingsworth J.W., et al. Ozone and pulmonary innate immunity. Proc. Am. Thorac. Soc. 4 (2007) 240-246
74. Guevara-Guzman R., et al. Estradiol prevents ozone-induced increases in brain lipid peroxidation and impaired social recognition memory in female rats. Neuroscience 159 (2009) 940-950
75. Pereyra-Munoz N., et al. Oxidative damage in substantia nigra and striatum of rats chronically exposed to ozone. J. Chem. Neuroanat. 31 (2006) 114-123
76. Angoa-Perez M., et al. Estrogen counteracts ozone-induced oxidative stress and nigral neuronal death. Neuroreport 17 (2006) 629-633
77. Rivas-Arancibia S., et al. Effect of acute ozone exposure on locomotor behavior and striatal function. Pharmacol. Biochem. Behav. 74 (2003) 891-900
78. Avila-Costa M.R., et al. Memory deterioration in an oxidative stress model and its correlation with cytological changes on rat hippocampus CA1. Neurosci. Lett. 270 (1999) 107-109
79. Gonzalez-Pina R., et al. Prenatal exposure to ozone disrupts cerebellar monoamine contents in newborn rats. Neurochem. Res. 33 (2008) 912-918
80. Araneda S., et al. VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure. Neurotoxicology 29 (2008) 920-927
81. Gutner U.A., et al. The influence of tumor necrosis factor alpha on the processes of sphingomyelin cycle and lipid peroxidation in brain. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 105 (2005) 48-54
82. Hermans C., et al. Effects of ambient ozone on the procoagulant status and systemic inflammatory response. J. Thromb. Haemost. 3 (2005) 2102-2103
83. Staal J.B., et al. Injection therapy for subacute and chronic low back pain: an updated Cochrane review. Spine 34 (2009) 49-59
84. Fuccio C., et al. A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Eur. J. Pharmacol. 603 (2009) 42-49
85. Seifert G., et al. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 7 (2006) 194-206
86. Damiani C.L., and O'Callaghan J.P. Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation. J. Neurochem. 100 (2007) 720-726
87. Zhou N.B., et al. Effects of different concentrations of oxygen-ozone on rats' astrocytes in vitro. Neurosci. Lett. 441 (2008) 178-182
88. Nimmerjahn A., et al. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005) 1314-1318
89. McGeer P.L., et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
90. Block M.L., et al. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J. 18 (2004) 1618-1620
91. Sama P., et al. The cellular and genomic response of an immortalized microglia cell line (BV2) to concentrated ambient particulate matter. Inhal. Toxicol. 19 (2007) 1079-1087
92. Blasko I., et al. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3 (2004) 169-176
93. Long T.C., et al. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol. 40 (2006) 4346-4352
94. Zhang P., et al. Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicol. Lett. 173 (2007) 88-100
95. Zhang P., et al. Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp. Neurol. 217 (2009) 219-230
96. McColl B.W., et al. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158 (2008) 1049-1061
97. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100 (2007) 158-173
98. Dallas S., et al. Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev. 58 (2006) 140-161
99. Miller D.S., et al. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol. Rev. 60 (2008) 196-209
100. Chen L., et al. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune Pharmacol. 3 (2008) 286-295
101. Hartz A.M., et al. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J. 22 (2008) 2723-2733
102. Lovell M.A., and Markesbery W.R. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 35 (2007) 7497-7504
103. Rahman M.F., et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 187 (2009) 15-21
104. Wang J., et al. Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases. Toxicol. Lett. 183 (2008) 72-80
105. Alekseenko A.V., et al. Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes. Brain. Res. 1241 (2008) 193-200